Ironwood Pharmaceuticals (IRWD) EPS (Basic) (2010 - 2026)
Ironwood Pharmaceuticals' (IRWD) quarterly EPS (Basic) came in at $0.31 in Q2 2026, up 113.8% year-over-year from $0.15 in Q2 2025, and up 25.07% quarter-over-quarter from $0.25 in Q1 2026.
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) EPS (Basic) (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has disclosed EPS (Basic) across 17 years of filings, most recently posting $0.31 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 113.8% year-over-year to $0.31; the TTM figure through Jun 2026 stood at $1.34 (up 131.22% YoY), while the FY2025 annual figure was $0.71, up 10.13% from the prior year.
- EPS (Basic) came in at $0.31 for Q2 2026 at Ironwood Pharmaceuticals, up from $0.25 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.65 in Q4 2024 to a low of -$7.01 in Q2 2023.
- Average EPS (Basic) over 5 years is -$0.18, with a median of $0.25 recorded in 2022.
- Year-over-year, EPS (Basic) plunged 2999.29% in 2023 and soared 2798.1% in 2025.
- Over 5 years, EPS (Basic) stood at $0.32 in 2022, then climbed by 10.4% to $0.35 in 2023, then jumped by 87.37% to $0.65 in 2024, then retreated by 16.14% to $0.55 in 2025, then sank by 43.19% to $0.31 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were $0.31 in Q2 2026, $0.25 in Q1 2026, and $0.55 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.56 Bn | 197.57 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 181.34 Bn | 178.16 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.55 Bn | 56.37 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.32 Bn | 49.19 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.32 Bn | 31.01 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.24 Bn | 29.95 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.17 Bn | 30.17 Bn | 1.16 Mn | -0.40 |
| 10 | Ironwood Pharmaceuticals | 671.59 Mn | 592.47 Mn | - | 0.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.31 |
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.55 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | -0.23 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | 0.35 |
| Sep 30, 2023 | 0.09 |
| Jun 30, 2023 | -7.01 |
| Mar 31, 2023 | 0.30 |
| Dec 31, 2022 | 0.32 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.25 |
| Sep 30, 2021 | 0.34 |